Indofarma Tbk. vs Venteny Fortuna International Tbk. — how do they compare? Indofarma Tbk. trades at Rp126 (market cap 390.51B), while Venteny Fortuna International Tbk. trades at Rp72 (market cap 476.15B, 21.68M 24h volume). The key difference: Venteny Fortuna International Tbk. is the larger of the two by market cap. Which is the better fit depends on your goals.
| INAF | VTNY | |
|---|---|---|
Market Cap | 390.51B | 476.15B |
Volume | — | 21.68M |
Lot | — | 216.81K |
Turnover | — | 1.59B |
Average Price | — | 73.22 |
Value | — | 1.59B |
Indicative Equilibrium Price | — | 72 |
Indicative Equilibrium Volume | — | 4.89K |
Trailing returns across standard periods
Latest headlines on both assets
PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.
Read more on INAF →PT Venteny Fortuna International Tbk (the Entity) was established based on Notarial Deed No. 7,dated January 29, 2021 of Anastasia Chandra, S.H., M.Kn., Notary in Tangerang. The Entity started its commercial operations in 2021. PT Venteny Fortuna International Tbk is the parent entity, whereas Junichiro Waide is the ultimate beneficial owner.
Read more on VTNY →